Targeted drugs and diagnostic assays: Companions in the race to combat ethnic disparity.

Abstract excerpt

African Americans (AAs) are more likely than European Americans to develop aggressive breast cancer subtypes, and have higher recurrence and mortality rates; this results in a stark breast-cancer related ethnic disparity in clinical outcomes. In this era of personalized oncology, companion diagnostics (CDx) are transforming the cancer treatment narrative slowly but steadily, by enabling the use of safety and/or...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Black or African American
• Share to Estrogen Receptor alpha